Antagonism of the chemokine Ccl5 ameliorates experimental liver fibrosis in mice-Reference-Cited by-同舟云学术

Antagonism of the chemokine Ccl5 ameliorates experimental liver fibrosis in mice

Published:2010-11-01 Issue:11 Volume:120 Page:4129-4140
ISSN:0021-9738
Container-title:Journal of Clinical Investigation
language:en
Short-container-title:J. Clin. Invest.

Author:

Berres Marie-Luise,Koenen Rory R.,Rueland Anna,Zaldivar Mirko Moreno,Heinrichs Daniel,Sahin Hacer,Schmitz Petra,Streetz Konrad L.,Berg Thomas,Gassler Nikolaus,Weiskirchen Ralf,Proudfoot Amanda,Weber Christian,Trautwein Christian,Wasmuth Hermann E.

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Reference43 articles.

1. Mechanisms of Hepatic Fibrogenesis

2. Liver fibrosis

3. Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ

4. Reversal of Fibrosis: No Longer a Pipe Dream?

5. Immune Interactions in Hepatic Fibrosis

Cited by 218 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oligonucleotide therapies for nonalcoholic steatohepatitis;Molecular Therapy - Nucleic Acids;2024-06

2. Fatty liver disease: time to target CCR5?;Expert Opinion on Therapeutic Targets;2024-05-03

3. Beyond Encapsulation: Exploring Macrophage-Fibroblast Cross Talk in Implant-Induced Fibrosis;Tissue Engineering Part B: Reviews;2024-03-27

4. The α‐1 Adrenergic Receptor Antagonist Doxazosin Attenuates Liver Fibrosis by Alleviating Sinusoidal Capillarization and Liver Angiogenesis;Advanced Biology;2024-03-17

5. Emerging therapies for MASLD and their impact on plasma lipids;American Journal of Preventive Cardiology;2024-03